These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 16585586

  • 1. Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin.
    Adamsson J, Lindblad M, Lundqvist A, Kelly D, Holmgren J, Harandi AM.
    J Immunol; 2006 Apr 15; 176(8):4902-13. PubMed ID: 16585586
    [Abstract] [Full Text] [Related]

  • 2. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J, Adamsson J, Harandi AM.
    Scand J Immunol; 2008 May 15; 67(5):431-40. PubMed ID: 18298617
    [Abstract] [Full Text] [Related]

  • 3. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.
    McCluskie MJ, Weeratna RD, Davis HL.
    Mol Med; 2000 Oct 15; 6(10):867-77. PubMed ID: 11126201
    [Abstract] [Full Text] [Related]

  • 4. Evidence for TLR4 and FcRγ-CARD9 activation by cholera toxin B subunit and its direct bindings to TREM2 and LMIR5 receptors.
    Phongsisay V, Iizasa E, Hara H, Yoshida H.
    Mol Immunol; 2015 Aug 15; 66(2):463-71. PubMed ID: 26021803
    [Abstract] [Full Text] [Related]

  • 5. Suppression of HIV replication in vitro by CpG and CpG conjugated to the non toxic B subunit of cholera toxin.
    Nowroozalizadeh S, Jansson M, Adamsson J, Lindblad M, Fenyö EM, Holmgren J, Harandi AM.
    Curr HIV Res; 2008 May 15; 6(3):230-8. PubMed ID: 18473786
    [Abstract] [Full Text] [Related]

  • 6. Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin.
    Cheng C, Bettahi I, Cruz-Fisher MI, Pal S, Jain P, Jia Z, Holmgren J, Harandi AM, de la Maza LM.
    Vaccine; 2009 Oct 19; 27(44):6239-46. PubMed ID: 19686693
    [Abstract] [Full Text] [Related]

  • 7. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.
    Zhang Y, Shoda LK, Brayton KA, Estes DM, Palmer GH, Brown WC.
    J Interferon Cytokine Res; 2001 Oct 19; 21(10):871-81. PubMed ID: 11711000
    [Abstract] [Full Text] [Related]

  • 8. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T, Wen ZK, Liu ZM, Qian C, Liang YJ, Jin ML, Cai YY, Xu L.
    Cancer Invest; 2008 Jun 19; 26(5):448-55. PubMed ID: 18568766
    [Abstract] [Full Text] [Related]

  • 9. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
    Yu C, An M, Li M, Liu H.
    Mol Pharm; 2017 Aug 07; 14(8):2815-2823. PubMed ID: 28686452
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells.
    Du HY, Xia SY, Song HF, Li N, Shang MM, Zou J, Wang QQ, Ou L, Sun X, Ji AG, Tang ZM.
    Acta Pharmacol Sin; 2007 Oct 07; 28(10):1637-44. PubMed ID: 17883951
    [Abstract] [Full Text] [Related]

  • 12. APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.
    Warren TL, Bhatia SK, Acosta AM, Dahle CE, Ratliff TL, Krieg AM, Weiner GJ.
    J Immunol; 2000 Dec 01; 165(11):6244-51. PubMed ID: 11086059
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
    Hong Z, Jiang Z, Liangxi W, Guofu D, Ping L, Yongling L, Wendong P, Minghai W.
    Int Immunopharmacol; 2004 Feb 01; 4(2):223-34. PubMed ID: 14996414
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis.
    Won TB, Quan SH, Kim DY, Rhee CS, Lee CH.
    Ann Allergy Asthma Immunol; 2009 Apr 01; 102(4):314-22. PubMed ID: 19441603
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis.
    Jassies-van der Lee A, Rutten V, Spiering R, van Kooten P, Willemse T, Broere F.
    Vet J; 2014 Apr 01; 200(1):103-8. PubMed ID: 24461202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.